Trexquant Investment’s CervoMed CRVO Stock Holding History

Trexquant Investment’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,087	Closed	-$71K	–	1436
2022 Q2	$71K	Buy	+7,087	New	+$87.9K	﹤0.01%	1453

Other funds holding CRVO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Trexquant Investment's CRVO Position: Q3 2022 in Review

Trexquant Investment sold out of CervoMed (CRVO) in Q3 2022, closing a stake of 7,087 shares — an estimated $71K sold.

Trexquant Investment first reported a position in CRVO in Q2 2022 and held it in 1 quarter. The position peaked at $71K in Q2 2022. 12 funds tracked by Wall St. Rank hold CRVO as of Q3 2022.

Trexquant Investment reported no remaining CervoMed position as of Q3 2022 after selling out during the quarter.
Trexquant Investment sold 7,087 CervoMed shares in Q3 2022, an estimated $71K.
Trexquant Investment first reported a position in CervoMed in Q2 2022 and held it in 1 quarter.
Trexquant Investment's CervoMed position peaked at $71K in Q2 2022.
12 funds tracked by Wall St. Rank held CervoMed as of Q3 2022.

Based on Trexquant Investment's 13F filing for Q3 2022, filed 14 Nov 2022.